diversification.com

CMPS

Companies
NASDAQ
Compass Pathways plc
Health Care
OverviewNewsRisk & CorrelationForecasts
Price Chart
Overview

About CMPS

compass pathways is a life sciences company dedicated to accelerating patient access to evidence-based innovation in mental health. our first major initiative is developing psilocybin therapy through late-stage clinical trials in the eu and us for patients with treatment-resistant depression. we are developing psychoactive care pathways based on advances in neuroscience, psychotherapy, psychopharmacology and digital platforms.

Market Cap
$474.6M
Volume
4.1M
Avg. Volume
4.7M
P/E Ratio
-1.315534
Dividend Yield
0.00%
Employees
186.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Medical Care Facilities
Latest News for CMPS

Psychedelics-Focused Compass Pathways Has Established Itself As 'Credible CNS Biotechnology Company,' Analyst Says

February 27, 2025

Peter Thiel-backed psychedelic start-up increases stake in Compass Pathways

November 29, 2021

Compass Pathways CEO on mushroom-based therapy for depression: 'The data was breathtaking'

November 9, 2021

COMPASS Pathways (CMPS) Upgraded to Buy: Here's What You Should Know

May 14, 2025
Risk & Correlation Analysis
Market Correlation
1.02
Moderate Correlation
Volatility
High (0.74)
Relative to market

Macro Factor Sensitivities

Interest Rates
Medium Sensitivity
Inflation
Low Sensitivity
GDP Growth
High Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for CMPS.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, CMPS shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$474.6M
Volume4.1M
P/E Ratio-1.32
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 27, 2025
Related Securities
MNMD
Mind Medicine (MindMed) Inc.
ATAI
Atai Life Sciences N.V.
XBI
SPDR S&P Biotech ETF
BTAI
BioXcel Therapeutics Inc.
IBB
iShares Biotechnology ETF
CYTK
Cytokinetics, Inc.

PortfolioPilot Analysis

Get AI-powered insights on how CMPS fits into your investment strategy and portfolio diversification.

Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025